Search
for
Sort by
Research 751–780 of 1000+
- Can plant‐derived phytochemicals provide symptom relief for hair loss? A critical review
- Diverse mechanisms for endogenous regeneration and repair in mammalian organs
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- JAK inhibitors in dermatology: The promise of a new drug class
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- 153 Effectiveness of OR-101, a next generation highly selective JAK3 inhibitor, in a humanized murine model of alopecia areata
- Deciphering the molecular drivers for cashmere/pashmina fiber production in goats: a comprehensive review
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata
- In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling
- In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- 0480 Upadacitinib monotherapy for treatment of pyoderma gangrenosum: A case series
- Tofacitinib in the Recalcitrant Cases of Alopecia Areata: A Pilot Study
- A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib
- 568 Novel synthetic melanin nanoparticles improve skin wound healing
- A Comprehensive Review on Alopecia: Mechanisms, Classification, and Therapeutic Strategies
- A Comprehensive Review on Alopecia: Mechanisms, Classification, and Therapeutic Strategies
- Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- LB1048 Effectiveness of OR-101 in a murine model of atopic dermatitis
- 6ER-014 Evaluation of baricitinib in paediatric patients with alopecia areata
- A review of Janus kinase inhibitor use in scarring alopecia
- Transcriptome analysis of frontal fibrosis alopecia revealed involvement of immune cells and ferroptosis
- A phase 2a trial of brepocitinib for cicatricial alopecia
- The Rho GTPase exchange factor Vav2 promotes extensive age-dependent rewiring of the hair follicle stem cell transcriptome
- Review of efficacy of baricitinib in the treatment of alopecia areata
- JAK Inhibitors for Treatment of Alopecia Areata
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience